ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

Clearinghouse Subgroup asks For Tests On Three Chemicals

October 7, 1977

Kennedy Agrees To Drop Dollar Limit In New Cancer Bill

January 11, 1980

Whole Brain Radiation Raises Risk Of Memory Problems

September 26, 2008